126 related articles for article (PubMed ID: 38266833)
1. Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity.
Hameed S; Saleem F; Özil M; Baltaş N; Salar U; Ashraf S; Ul-Haq Z; Taha M; Khan KM
Int J Biol Macromol; 2024 Apr; 263(Pt 2):129517. PubMed ID: 38266833
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
[TBL] [Abstract][Full Text] [Related]
3. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases.
Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA
Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518
[TBL] [Abstract][Full Text] [Related]
4. Phytochemical Profile, Antioxidant, Enzyme Inhibition, Acute Toxicity, In Silico Molecular Docking and Dynamic Analysis of Apis Mellifera Propolis as Antidiabetic Supplement.
Syaifie PH; Ibadillah D; Jauhar MM; Reninta R; Ningsih S; Ramadhan D; Arda AG; Ningrum DWC; Kaswati NMN; Rochman NT; Mardliyati E
Chem Biodivers; 2024 Jun; 21(6):e202400433. PubMed ID: 38584139
[TBL] [Abstract][Full Text] [Related]
5. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of obovatol and related neolignan analogues as α-glucosidase and α-amylase inhibitors.
Sciacca C; Cardullo N; Pulvirenti L; Travagliante G; D'Urso A; D'Agata R; Peri E; Cancemi P; Cornu A; Deffieux D; Pouységu L; Quideau S; Muccilli V
Bioorg Chem; 2024 Jun; 147():107392. PubMed ID: 38723423
[TBL] [Abstract][Full Text] [Related]
7. The antihyperglycemic potential of pyrazolobenzothiazine 1, 1-dioxide novel derivative in mice using integrated molecular pharmacological approach.
Taj S; Ashfaq UA; Ahmad M; Noor H; Ikram A; Ahmed R; Tariq M; Masoud MS; Hasan A
Sci Rep; 2024 Apr; 14(1):7746. PubMed ID: 38565861
[TBL] [Abstract][Full Text] [Related]
8. Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
Hameed S; Khan KM; Salar U; Özil M; Baltaş N; Saleem F; Qureshi U; Taha M; Ul-Haq Z
Int J Biol Macromol; 2022 Nov; 221():1294-1312. PubMed ID: 36113601
[TBL] [Abstract][Full Text] [Related]
9. Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.
Chahal S; Rani P; Shweta ; Goel KK; Joshi G; Singh R; Kumar P; Singh D; Sindhu J
Bioorg Chem; 2024 Jun; 147():107363. PubMed ID: 38657527
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
Kothari M; Kannan K; Sahadevan R; Sadhukhan S
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and In Vitro α-Amylase and α-Glucosidase Dual Inhibitory Activities of 1,2,4-Triazole-Bearing
Khan I; Rehman W; Rahim F; Hussain R; Khan S; Rasheed L; Alanazi MM; Alanazi AS; Abdellattif MH
ACS Omega; 2023 Jun; 8(25):22508-22522. PubMed ID: 37396210
[TBL] [Abstract][Full Text] [Related]
12. Bioevaluation of synthetic pyridones as dual inhibitors of α-amylase and α-glucosidase enzymes and potential antioxidants.
Saleem F; Khan KM; Ullah N; Özil M; Baltaş N; Hameed S; Salar U; Wadood A; Rehman AU; Kumar M; Taha M; Haider SM
Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200400. PubMed ID: 36284484
[TBL] [Abstract][Full Text] [Related]
13. Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis,
Ghannay S; Aldhafeeri BS; Ahmad I; E A E Albadri A; Patel H; Kadri A; Aouadi K
Heliyon; 2024 Feb; 10(4):e25911. PubMed ID: 38380049
[TBL] [Abstract][Full Text] [Related]
14. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
Singh G; Singh R; Monga V; Mehan S
Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity.
Aroua LM; Alosaimi AH; Alminderej FM; Messaoudi S; Mohammed HA; Almahmoud SA; Chigurupati S; Albadri AEAE; Mekni NH
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839780
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonic-Assisted Synthesis of Heterocyclic Curcumin Analogs as Antidiabetic, Antibacterial, and Antioxidant Agents Combined with in vitro and in silico Studies.
Zelelew D; Endale M; Melaku Y; Geremew T; Eswaramoorthy R; Tufa LT; Choi Y; Lee J
Adv Appl Bioinform Chem; 2023; 16():61-91. PubMed ID: 37533689
[TBL] [Abstract][Full Text] [Related]
17.
Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities.
Khirallah SM; Ramadan HMM; Aladl HAA; Ayaz NO; Kurdi LAF; Jaremko M; Alshawwa SZ; Saied EM
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559028
[TBL] [Abstract][Full Text] [Related]
19. Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis,
Bukhari A; Nadeem H; Imran M; Muhammad SA
Iran J Basic Med Sci; 2021 Dec; 24(12):1632-1642. PubMed ID: 35432813
[TBL] [Abstract][Full Text] [Related]
20. Alpha-amylase Inhibition and Antioxidant Activity of Marine Green Algae and its Possible Role in Diabetes Management.
Unnikrishnan PS; Suthindhiran K; Jayasri MA
Pharmacogn Mag; 2015 Oct; 11(Suppl 4):S511-5. PubMed ID: 27013787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
